Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 9, 2026

The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%

View original at nasdaq.com
The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • More than 10,000 rare diseases exist today but only 5% have approved medicines

    80% confidence
  • Verizon is falling short of its potential and needs to improve loyalty, retention, and operational efficiency

    80% confidence
  • GLP-1 drugs can't put a dent in Coca-Cola despite worries from bears

    80% confidence
  • Keytruda won't start to lose exclusivity until late 2028

    80% confidence
  • U.S. housing market is begging for investment - industry has been underbuilding for years and nearly three-quarters of existing homes are 25 years old or greater

    80% confidence
  • Dogs of the Dow strategy works because it is contrarian - high yields for blue chips signal value as these stocks are out of favor, not going out of business

    80% confidence
  • 5 Hidden Yield dividend stocks are poised to deliver 15% annualized returns - enough to double investment every 5 years

    80% confidence
  • Uncertain economic environment with mixed indicators - some like GDP and PCE are strong, but housing pressure and consumer uncertainty are impacting home improvement

    80% confidence
  • Experts estimate it would take tens of billions of dollars of investment and many years to meaningfully ramp up oil production in Venezuela

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% — Source | Via News | Via News